Highlights

Por Jia-Horng Kao
Publicado em 2022-06-01

Highlights

Por Jia-Horng Kao
Publicado em 2022-05-01

Highlights

Por Jia-Horng Kao
Publicado em 2020-02-01

Strategies for hepatitis C virus treatment failure

Por Shang-Chin Huang, Jia-Horng Kao
Publicado em 2022-05-01

Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan

Por Ching-Sheng Hsu, Jia-Horng Kao
Publicado em 2012-10-01

Milder clinical manifestation of scrub typhus in Kinmen, Taiwan

Por Tung-Hung Su, Chun-Jen Liu, Ding-Shinn Chen, Jia-Horng Kao
Publicado em 2013-04-01

Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy

Por Chih-Lin Lin, Kuo-Chih Tseng, Kuan-Yang Chen, Li-Ying Liao, Jia-Horng Kao
Publicado em 2020-10-01

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients.

Por Huei-Ru Cheng, Chun-Jen Liu, Tai-Chung Tseng, Tung-Hung Su, Hwai-I Yang, Chien-Jen Chen, Jia-Horng Kao
Publicado em 2013-01-01

Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients.

Por Ching-Sheng Hsu, Chun-Jen Huang, Jia-Horng Kao, Hans Hsienhong Lin, You-Chen Chao, Yen-Chun Fan, Pei-Shan Tsai
Publicado em 2013-01-01

De novo assembly of highly polymorphic metagenomic data using in situ generated reference sequences and a novel BLAST-based assembly pipeline

Por You-Yu Lin, Chia-Hung Hsieh, Jiun-Hong Chen, Xuemei Lu, Jia-Horng Kao, Pei-Jer Chen, Ding-Shinn Chen, Hurng-Yi Wang
Publicado em 2017-04-01

Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents

Por Shang-Chin Huang, Pin-Nan Cheng, Chen-Hua Liu, Hung-Chih Yang, Tung-Hung Su, Tai-Chung Tseng, Pei-Jer Chen, Jia-Horng Kao, Chun-Jen Liu
Publicado em 2022-05-01

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

Por Hsing-Yu Chen, Tung-Hung Su, Tai-Chung Tseng, Wan-Ting Yang, Ting-Chih Chen, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao, Chun-Jen Liu
Publicado em 2017-09-01

HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients

Por Cheng-Yuan Peng, Tsung-Cheng Hsieh, Tsai-Yuan Hsieh, Kuo-Chih Tseng, Chih-Lin Lin, Tung-Hung Su, Tai-Chung Tseng, Hans Hsienhong Lin, Chia-Chi Wang, Jia-Horng Kao
Publicado em 2015-04-01

Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C

Por Shih-Jer Hsu, Min-Chin Chiu, Yu-Jen Fang, Tsung-Hua Yang, Jian-Jyun Yu, Chieh-Chang Chen, Chia-Chi Kuo, Ji-Yuh Lee, Chien-Hung Chen, Ding-Shinn Chen, Jia-Horng Kao
Publicado em 2019-08-01

Permanent Inactivation of HBV Genomes by CRISPR/Cas9-Mediated Non-cleavage Base Editing

Por Yu-Chan Yang, Yu-Hsiang Chen, Jia-Horng Kao, Chi Ching, I-Jung Liu, Chih-Chiang Wang, Cheng-Hsueh Tsai, Fang-Yi Wu, Chun-Jen Liu, Pei-Jer Chen, Ding-Shinn Chen, Hung-Chih Yang
Publicado em 2020-06-01